益丰药房：益丰药房2023年年度报告（英文版）.PDF

1、2023 Annual Report 1/329 Company code:603939 Company abbreviation:Yifeng Pharmacy Yifeng Pharmacy Chain Co.,Ltd.2023 Annual Report 2023 Annual Report 2/329 Important Notes I.The Board of Directors,Board of Supervisors,directors,supervisors and senior management of the Company hereby guarantee that t

2、he contents are authentic,accurate,and complete,without false records,misleading representations or material omissions in the Annual Report,and shall take all the joint and several legal liabilities.II.All the directors have attended the meeting of the Board of Directors.III.Pan-China Certified Publ

3、ic Accountants(special general partnership)has issued a standard unqualified audit report for the Company.IV.Gao Yi,the Companys responsible person,Deng Jianqin,responsible person in charge of accounting work,and Guan Changfu,the accounting firms responsible person(accounting superintendent)hereby d

4、eclare and warrant that the financial report in the Annual Report is authentic,accurate,and complete.V.The profit distribution plan or the capital reserve capitalization plan for the Reporting Period has been approved by the Board of Directors In 2023,the Company achieved a net profit attributable t

5、o the parent company amounting to CN 1,411,985,024.41.After adding the undistributed profit from the beginning of 2023,which was CN 3,717,157,469.99,and deducting the statutory surplus reserve of CN 66,216,102.98 extracted at the end of the year,along with a dividend payout of CN 288,681,972.00 for

6、2023,the profit available for distribution to shareholders totaled CN 4,774,244,419.42.The Company plans to distribute a cash dividend of CN 0.50 per share(tax included)to all shareholders,based on the total share capital as recorded on the equity distribution date of 2023.Additionally,it will incre